STUDY OF OCTAPLEX, A FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) AND BERIPLEX® P/N (KCENTRA) FOR THE REVERSAL OF VITAMIN K ANTAGONIST (VKA) INDUCED ANTICOAGULATION IN PATIENTS NEEDING URGENT SURGERY WITH SIGNIFICANT BLEEDING RISK.: